Mammoth Biosciences
Biotechnology, 1000 Marina BLVD, Brisbane, California, 94005, United States, 51-200 Employees
Phone Number: +16*********
Who is MAMMOTH BIOSCIENCES
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications suc...
Read More
-
Headquarters: 1000 Marina BLVD, Brisbane, California, 94005, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7375
|
NAICS Code: 517810 |
Show More
Does something look wrong? Fix it. | View contact records from MAMMOTH BIOSCIENCES
Mammoth Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Mammoth Biosciences
Answer: Mammoth Biosciences's headquarters are located at 1000 Marina BLVD, Brisbane, California, 94005, United States
Answer: Mammoth Biosciences's phone number is +16*********
Answer: Mammoth Biosciences's official website is https://mammoth.bio
Answer: Mammoth Biosciences's revenue is $1 Million to $5 Million
Answer: Mammoth Biosciences's SIC: 7375
Answer: Mammoth Biosciences's NAICS: 517810
Answer: Mammoth Biosciences has 51-200 employees
Answer: Mammoth Biosciences is in Biotechnology
Answer: Mammoth Biosciences contact info: Phone number: +16********* Website: https://mammoth.bio
Answer: Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the companys ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoths deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month